cherry throat relief lozenges
NDC 42961-401, benzocaine, lozenge, from Cintas Corporation.
- Product NDC
- 42961-401
- Status
- Listed
- Labeler
- Cintas Corporation
- Dosage form
- LOZENGE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42961-401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MENTHOL3.6 mg/1
- BENZOCAINE15 mg/1
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42961-401-18 | 42961040118 | 18 LOZENGE in 1 BLISTER PACK (42961-401-18) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 42961-401 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42961-401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42961-401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.